Clinical Trial Update: Deescalating Carbapenems in Hospital Setting [Phase 4]

View source ↗

Summary

A Phase 4 trial evaluating de-escalation of carbapenems in hospitalized patients with urinary tract, intra-abdominal, and biliary tract infections was terminate…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Biliary Tract Infection
• Intra-abdominal Infection
• Urinary Tract Infection

Drugs mentioned

• Doripenem (Doribax) (doripenem)
• Ertapenem (Invanz) (ertapenem)
• Imipenem/cilastatin (Primaxin) (imipenem/cilastatin)
• Meropenem (Merrem) (meropenem)

Snippet

Sponsor: Assistance Publique - Hôpitaux de Paris | Conditions: Urinary Infection, Digestive Infection | Phase 4 | Status: TERMINATED